How New Drug Approvals are Reshaping Treatment for Eosinophilic Esophagitis
University of North Carolina School of MedicineThe FDA has approved two medications for the treatment of eosinophilic esophagitis (EoE)—the first oral medication tailored for adults and the exclusive therapeutic option for children. Evan Dellon, MD, MPH, internationally known for his work with EoE, and colleagues continue to focus on optimizing usage for effective, personalized outcomes.